Treatment pattern over 24 months after LAMA or LABA monotherapy
| LAMA (N=4,373) | |
| Discontinued* | 36% |
| Added ICS containing medicine** | 30% |
| Added LABA | 5% |
| Switched to ICS containing medicine** | 5% |
| Switched to LABA | 1% |
| LABA (N=894) | |
| Discontinued* | 43% |
| Added ICS containing medicine** | 3% |
| Added LAMA | 16% |
| Switched to ICS containing medicine** | 4% |
| Switched to LAMA | 15% |
*Did not have another LAMA (or LABA) monotherapy during follow-up.**Inhaled corticosteroid (ICS) alone or ICS/LABA.